It is estimated that the majority of breast cancer subtypes are responsive to sex steroid hormones (particularly estrogen and progesterone) due to their expression of classic estrogen receptors (ERs), classic progesterone receptors (nPRs), or both, and are therefore termed hormone-responsive cancers [4,5]. This evidence concerns the gene ESR1 and breast carcinoma.